Roayaie S, Guarrera JV, Ye MQ, et al. (1998) Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg, 187(4):365-372
CODE: ICCSR98
Abstract: Median actuarial survivals were 42.9 6 8.9 months for resectable and 6.7 6 3.6 months for unresectable patients (p 5 0.005). Noncurative resection offers a survival advantage over no resection.
Introduction: Lack of etiologic factors such as intrahepatic lithiasis and liver flukes make this tumor 10 times less prevalent in Western countries.3,4
Discussion
A randomized prospective trial is needed but is unlikely to take place because the incidence of this disease is so low.
CODE: ICCSR98
Abstract: Median actuarial survivals were 42.9 6 8.9 months for resectable and 6.7 6 3.6 months for unresectable patients (p 5 0.005). Noncurative resection offers a survival advantage over no resection.
Introduction: Lack of etiologic factors such as intrahepatic lithiasis and liver flukes make this tumor 10 times less prevalent in Western countries.3,4
Discussion
A randomized prospective trial is needed but is unlikely to take place because the incidence of this disease is so low.
No comments:
Post a Comment